Paul La Rosée

Schwarzwald-Baar Klinikum — Germany

Medicine · Health Sciences

45h-index10.1kcitations216works12.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Chronic Myeloid Leukemia Treatments(79), Chronic Lymphocytic Leukemia Research(66), Autoimmune and Inflammatory Disorders Research(52), Lymphoma Diagnosis and Treatment(44), Eosinophilic Disorders and Syndromes(37)

Publications213 total

Treatment expectations and goals among patients with chronic myeloid leukemia in Germany: a patient-centered perspective
Leukemia·2025· 1 citedOpen Access
Hemophagocytic lymphohistiocytosis: do we have a solution for TMI (too much inflammation)?
Hematology·2025Open Access
Macrophage Activation-Like Syndrome in critically ill patients with sepsis: high risk patients with high mortality
Anaesthesia Critical Care & Pain Medicine·2025Open Access
Tissue‐Resident Myeloid and Histiocytic Cells in Health and Disease: Novel Emerging Concepts
American Journal of Hematology·2025Open Access
Case Report: Late-onset primary hemophagocytic lymphohistiocytosis leading to the diagnosis of Griscelli syndrome type 2 in a young woman with phenotypically inapparent partial albinism
Frontiers in Immunology·2025· 1 citedOpen Access
HLH: it is all about communication
Blood·2025Open Access
Prognostic Impact of COVID-19 Inflammation Score Response: A Sub-Group Analysis on Critically Ill Patients of the RuxCoFlam Trial
Life·2025Open Access
Multicenter validation of secondary hemophagocytic lymphohistiocytosis diagnostic criteria
Journal of Internal Medicine·2025· 19 citedOpen Access
Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy for Transplant-Eligible Newly Diagnosed Multiple Myeloma: Final Part 1 Analysis of the GMMG-HD7 Trial
Journal of Clinical Oncology·2024· 49 citedOpen Access
HLH: diagnostics revisited and improved
Blood·2024· 15 cited
Response-guided first-line therapy and treatment of relapse in aggressive lymphoma: 10-year follow-up of the PETAL trial
Blood Neoplasia·2024· 3 citedOpen Access
Value of hemophagocytosis in the diagnosis of hemophagocytic lymphohistiocytosis in critically ill patients
European Journal Of Haematology·2024· 7 citedOpen Access
Elotuzumab, lenalidomide, bortezomib, dexamethasone, and autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GMMG-HD6): results from a randomised, phase 3 trial
The Lancet Haematology·2024· 17 citedOpen Access
Lymphoma-associated hemophagocytic lymphohistiocytosis (LA-HLH): a scoping review unveils clinical and diagnostic patterns of a lymphoma subgroup with poor prognosis
Leukemia·2024· 49 citedOpen Access
Final Results from RIBBIT: A Randomized Phase III Study to Evaluate Efficacy and Quality of Life in Patients with Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer Receiving Ribociclib in Combination with Endocrine Therapy or Chemotherapy with or without Bevacizumab in the First-Line Setting
Breast Care·2023· 3 citedOpen Access
A prospective observational study of real-world treatment and outcome in secondary CNS lymphoma
European Journal of Cancer·2023· 4 cited
Treatment Free Remission after Nilotinib Plus Peg-Interferon Alpha Induction and Peg-Interferon Alpha Maintenance Therapy for Newly Diagnosed Chronic Myeloid Leukemia Patients; The Tiger Trial
Blood·2023· 19 cited
Single-Center Experience of Decitabine/Venetoclax in Newly Diagnosed Older AML Patients with Non-Favorable Genetics: Bridging to Allo-HCT or Treatment Continuation
Blood·2023· 1 cited
Addendum to the German Consensus Recommendations on Ponatinib in the Treatment of Chronic Myeloid Leukemia
Acta Haematologica·2023· 1 citedOpen Access
Behandlung der hämophagozytischen Lymphohistiozytose bei Patienten auf der Intensivstation
Die Innere Medizin·2023· 2 cited
page 1 of 11Next →

Frequent Co-authors

Andreas Hochhaus(16), Gunnar Lachmann(9), Gritta Janka(8), Brian Druker(8), Frank M. Brunkhorst(8), Thomas Schenk(8), Michael W. Deininger(6), Claudia Spies(6), Michael B. Jordan(5), Bernd Hertenstein(5), Cornelia Knaak(5), Peter Nyvlt(5), Friederike S. Schuster(5), Felix Balzer(5), Didier Keh(5), Thomas Ernst(5), Tatiana von Bahr Greenwood(4), Sebastian Birndt(4), Jan‐Inge Henter(4), Nicholas C.P. Cross(4)